Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 18.
doi: 10.1038/s41586-024-08165-7. Online ahead of print.

Adipose tissue retains an epigenetic memory of obesity after weight loss

Affiliations

Adipose tissue retains an epigenetic memory of obesity after weight loss

Laura C Hinte et al. Nature. .

Abstract

Reducing body weight to improve metabolic health and related comorbidities is a primary goal in treating obesity1,2. However, maintaining weight loss is a considerable challenge, especially as the body seems to retain an obesogenic memory that defends against body weight changes3,4. Overcoming this barrier for long-term treatment success is difficult because the molecular mechanisms underpinning this phenomenon remain largely unknown. Here, by using single-nucleus RNA sequencing, we show that both human and mouse adipose tissues retain cellular transcriptional changes after appreciable weight loss. Furthermore, we find persistent obesity-induced alterations in the epigenome of mouse adipocytes that negatively affect their function and response to metabolic stimuli. Mice carrying this obesogenic memory show accelerated rebound weight gain, and the epigenetic memory can explain future transcriptional deregulation in adipocytes in response to further high-fat diet feeding. In summary, our findings indicate the existence of an obesogenic memory, largely on the basis of stable epigenetic changes, in mouse adipocytes and probably other cell types. These changes seem to prime cells for pathological responses in an obesogenic environment, contributing to the problematic 'yo-yo' effect often seen with dieting. Targeting these changes in the future could improve long-term weight management and health outcomes.

PubMed Disclaimer

Conflict of interest statement

Competing interests M.B. received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer-Ingelhiem, Lilly, Novo Nordisk and Sanofi. M.R. received honoraria as a consultant and speaker from AstraZeneca, Boehringer-Ingelheim, Lilly, Novo Nordisk and Sanofi. The other authors declare no competing interests.

References

    1. Zimmet, P., Alberti, K. G. M. M. & Shaw, J. Global and societal implications of the diabetes epidemic. Nature 414, 782–787 (2001). - PubMed - DOI
    1. Wolfe, B. M., Kvach, E. & Eckel, R. H. Treatment of obesity: weight loss and bariatric surgery. Circ. Res. 118, 1844 (2016). - PubMed - PMC - DOI
    1. Nordmo, M., Danielsen, Y. S. & Nordmo, M. The challenge of keeping it off, a descriptive systematic review of high‐quality, follow‐up studies of obesity treatments. Obes. Rev. 21, e12949 (2020). - PubMed - DOI
    1. Contreras, R. E., Schriever, S. C. & Pfluger, P. T. Physiological and epigenetic features of yoyo dieting and weight control. Front. Genet. 10, 1015 (2019). - PubMed - PMC - DOI
    1. Franz, M. J. et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J. Am. Diet. Assoc. 107, 1755–1767 (2007). - PubMed - DOI

LinkOut - more resources